Hong Kong-Based Secondaries Specialist TR Capital Eyes $300M For New PE Fund

Eudora Wang
May 14, 2019 — 13:29 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: acquisition biotech Bytedance chinese finance healthcare Hong Kong internet investment medicine online video Pacific Private Equity Shanghai technology TR Capital TR Capital IV Website

Related News:

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

Middle Eastern Sovereign Wealth Funds Deepen Investment in China

November 10, 2023 — 23:35

KKR Leads $180 Million Series F Round In Newly-Minted Asian Unicorn Livspace

February 15, 2022 — 03:32

US-Listed Chinese Companies Rush To List In Hong Kong

January 28, 2021 — 07:25

Chinese Investors Jump On The SPAC Bandwagon

January 27, 2021 — 06:02

KKR Closes $3.9 Billion APAC Infrastructure Fund

January 12, 2021 — 00:32

SAIC Injects RMB500 Million In Chinese EV Maker WM Motor

September 12, 2020 — 03:10

Ardian Closes $19 Billion For Secondary Funds And Co-Investments

June 4, 2020 — 05:35

Softbank, Hillhouse Back Chinese Zillow-Like Real Estate Platform Shell Zhaofang

March 5, 2020 — 22:27